Literature DB >> 11913680

Association of Epstein-Barr virus and nasopharyngeal carcinoma in Caucasian patients.

Guillermo Plaza1, Ana I Manzanal, Luis Fogué, Almudena Santón, Juan Carlos Martínez-Montero, Carmen Bellas.   

Abstract

We evaluated the association of nasopharyngeal carcinoma (NPC) and Epstein-Barr virus (EBV) in Spanish patients, and studied the expression of EBV products (latent membrane protein-1 [LMP-1] and ZEBRA proteins) by NPC cells and its possible prognostic value. In situ hybridization (ISH) for EBV-encoded nonpolyadenylated RNAs (EBERs) and immunohistochemical expression of LMP-1 and ZEBRA proteins by immunohistochemistry were examined in formalin-fixed, paraffin-embedded NPC specimens from 30 patients, and a survival analysis was done by the Kaplan-Meier method. We detected EBERs by ISH in 96.67% of the NPC cases, and detected expression of LMP-I in 43.33% of the NPC cases and expression of ZEBRA protein in 6.67% of the NPC cases. We conclude that ISH for expression of EBERs is an adequate method for detection of EBV in NPC. LMP-1 is not frequently expressed in NPC cells (43.33%). Most NPC cells carry a latent EBV infection. LMP-1 expression might have worsened the prognosis of NPC in our series.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11913680     DOI: 10.1177/000348940211100304

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  5 in total

Review 1.  Cancers associated with human gammaherpesviruses.

Authors:  Kwun Wah Wen; Linlin Wang; Joshua R Menke; Blossom Damania
Journal:  FEBS J       Date:  2021-09-18       Impact factor: 5.622

2.  Expression of Epstein-Barr-virus-encoded small nuclear RNA in nasopharyngeal carcinomas of Aegean Turkish patients.

Authors:  Yeşim Ertan; Mine Hekimgil; Serap Karaarslan; Saliha Soydan
Journal:  Virchows Arch       Date:  2008-02-26       Impact factor: 4.064

3.  Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel.

Authors:  G Bar-Sela; A Kuten; I Minkov; E Gov-Ari; O Ben-Izhak
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

4.  Nasopharyngeal carcinoma: our experience.

Authors:  Carla d'Espiney Amaro; Pedro Montalvão; Pedro Henriques; Miguel Magalhães; João Olias
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-10-02       Impact factor: 2.503

5.  Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up.

Authors:  Su-Mei Cao; Zhiwei Liu; Wei-Hua Jia; Qi-Hong Huang; Qing Liu; Xiang Guo; Teng-Bo Huang; Weimin Ye; Ming-Huang Hong
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.